Talquetamab User Reviews & Ratings
Brand names: Talvey
Talquetamab has an average rating of 6.8 out of 10 from a total of 4 reviews on Drugs.com. 25% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Multiple Myeloma | 4 reviews for Multiple Myeloma | 72 medications |
- Ano...
- Taken for 6 months to 1 year
- August 12, 2025
Talquetamab for Multiple Myeloma "I experienced CRS syndrome along with a severe rash when I began taking Talvey 10 months ago. The frequency of my injections was extended from bi-weekly to every 3 weeks, which helped with the side effects."
- Ano...
- Taken for 1 to 6 months
- June 17, 2025
Talquetamab for Multiple Myeloma "Loss of taste. Very dizzy and disoriented. But it controls the myeloma. Side effects might not be worth it at 85 years old."
- Jer...
- Taken for 1 to 6 months
- January 25, 2025
Talquetamab for Multiple Myeloma "It's keeping me alive, but my quality of life is very bad."
See also:
More about talquetamab
- Check interactions
- Compare alternatives
- Reviews (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: bispecific T-cell engagers (BiTE)
- Breastfeeding
- En español
For Multiple Myeloma "Achieved MRD negative within a month of starting treatment. Side effects worse than any other treatment. Food was tasteless, lost 15 pounds. Throat closure issues made eating difficult. Still can’t eat or swallow meat. Nails fell off. Remission only lasted 8 months."